Address common misperceptions about risks associated with inflammatory bowel disease (IBD) and its treatment during pregnancy. This on-demand, interactive video is intended to improve participants’ ability to apply evidence-based medicine and expert commentary in developing family planning strategies that can help ensure women with IBD safe and effective control of their disease before and during pregnancy. The program, developed by a collaboration between AGA and Clinical Care Options, is divided into segments with question and answer checkpoints that allow learners to review on their own schedule.
Sign in to access
After you sign in, please click the "Launch" button on the top of this page to access the course.
Features
This interactive video is divided into six short segments.
- Overview (4 minutes)
Clinical overview of IBD in women of childbearing age, including common misperceptions.
- IBD, fertility, genetics (10 minutes)
Evidence-based discussion of fertility rates in women with IBD.
- IBD treatments in conception, pregnancy, breastfeeding (21 minutes)
Expert discussion of managing therapeutic decisions for IBD during pregnancy.
- IBD and delivery (8 minutes)
Experts address misperceptions about delivery options for pregnant women with IBD.
- Postdelivery care (10 minutes)
Preventing and managing postpartum flares in women with IBD.
- Summary (4 minutes)
Experts summarize the key take-home messages regarding managing IBD in women of childbearing age.
Learning objectives
Upon completion of this activity, participants should be able to:
- Summarize the evidence for successful pregnancy in women with IBD that can be conveyed to patients who desire to become pregnant.
- Outline the key tenets of caring for women with IBD who wish to become pregnant, including preconception counseling and the importance of a multidisciplinary team.
- Detail preconception IBD medical management recommended by AGA regarding conventional and biologic therapies.
Faculty
Uma Mahadevan, MD, AGAF
Professor of Medicine
Division of Gastroenterology, Department of Medicine
UCSF
Co-Director
UCSF Center for Colitis and Crohn’s Disease
San Francisco, California
Marla Dubinsky, MD
Chief of Pediatric Gastroenterology and Nutrition
Co-Director
Susan and Leonard Feinstein IBD Clinical Center
Icahn School of Medicine
Mount Sinai, New York
Pricing
|
Member
|
Nonmember
|
$Free
|
$Free |
Accreditation and designation
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AGA Institute designates this enduring material activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME expiration date: March 24, 2021
Uma Mahadevan, MD, had disclosed that she has received consulting fees from AbbVie, Allergan, Bristol-Myers Squibb, Gilead Sciences, Janssen, and Takeda and funds for research support from Celgene and Pfizer.
Marla Dubinsky, MD, has disclosed that she has received consulting fees from AbbVie, Arena, Bristol-Myers Squibb, Celgene, Genentech, Janssen, Lilly, Pfizer, Prometheus and Takeda; has received funds for research support from AbbVie, Janssen, Pfizer and Prometheus; has received royalties from Mi Test Health; and has ownership interest in Trellus Health.
